Developed by Ireland-based BrePco Biopharma, Neoatricon is the first paediatric-strength dopamine hydrochloride infusion for ...

Jaipur: A new study from JK Lon Hospital, state's largest govt paediatric facility, has revealed significant deficiencies in ...

Neonates require potent antiretroviral drugs (ARVs) against HIV but there are fewer drugs available for children compared to ...

BrePco Biopharma Limited today announced that the UK Medicines and Healthcare products Regulatory Agency issued a grant of a ...

Piramal Critical Care and BrePco Biopharma received UK approval for Neoatricon, a paediatric Dopamine Hydrochloride solution.

The global vitamin K2 market is rapidly growing due to its role in preventing cardiovascular diseases and supporting bone ...

Piramal Critical Care, a part of Piramal Pharma, and Ireland-based BrePco Biopharma have received marketing approval from the ...

Piramal Critical Care and BrePco Biopharma have secured UK approval for Neoatricon, a medication for low blood pressure and ...

Miniaturized pacemakers were successfully implanted in infants and neonates requiring pacing and performed reliably until ...

Rationale Preterm neonates needing rescue treatments with inotropes and/or inhaled nitric oxide (iNO) (acute critical illnesses, ACIs) in neonatal intensive care units (NICUs) are at high risk of ...